Laid - 3 Sep 2024 In Force 1 Oct 2024
These Regulations amend the Ionising Radiation (Medical Exposure) Regulations 2017 (S.I. 2017/1322) (“the 2017 Regulations”). These Regulations are being issued free of charge to those who purchased the Ionising Radiation (Medical Exposure) (Amendment) Regulations 2018 (S.1 2018/121) (“the 2018 Regulations”). The 2018 Regulations made amendments to the 2017 Regulations which …
Laid - 3 Sep 2024 In Force 1 Oct 2024
These Regulations amend the Personal Injuries (NHS Charges) (Amounts) Regulations 2015 (S.I. 2015/295) (“the principal Regulations”) which make provision about the charges payable under the scheme for recovery of NHS charges in cases where an injured person who receives a compensation payment in respect of their injury has received NHS …
Laid - 3 Sep 2024 In Force Not stated
These Regulations amend the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (“the PLPS Regulations”). The PLPS Regulations govern the arrangements in England, under Part 7 of the National Health Service Act 2006 (“the 2006 Act”), for the provision of pharmaceutical and local pharmaceutical services.
Laid - 22 Aug 2024 In Force Not stated
This Order prohibits, subject to exceptions, the retail sale, and the supply in circumstances corresponding to retail sale, of medicinal products that consist of or contain a list of gonadotrophin-releasing hormone (“GnRH”) analogues (article 3). It is the second such Order – and, as it applies in Great Britian, it …
Laid - 30 Jul 2024 In Force 1 Sep 2024
These Regulations amend the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (“the PLPS Regulations”). The PLPS Regulations govern the arrangements in England, under Part 7 of the National Health Service Act 2006 (“the 2006 Act”), for the provision of NHS pharmaceutical and local pharmaceutical services.
Laid - 29 Jul 2024 In Force Not stated
These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use.
Laid - 29 Jul 2024 In Force 1 Jan 2025
The United Kingdom (“UK”) and the European Union (“EU”) agreed to the Windsor Framework in March 2023, including new arrangements relating to the supply of medicines from Great Britain (“GB”) to Northern Ireland (“NI”) (“the Agreement”) to come into effect in January 2025.
Laid - 29 May 2024 In Force 26 Jun 2024
These Regulations amend the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004 (“the 2004 Regulations”). The 2004 Regulations prohibit or restrict the ordering of specified prescription items under a general medical services (GMS) contract in England.
Laid - 29 May 2024 In Force 3 Jun 2024
This Order prohibits, subject to exceptions, the retail sale, and the supply in circumstances corresponding to retail, of medicinal products that consist of or contain a list of gonadotrophin-releasing hormone (“GnRH”) analogues (article 3).
Laid - 23 May 2024 In Force 28 Jun 2024
Regulation 2 amends Regulation (EC) No. 1333/2008 of the European Parliament and of the Council on food additives (EUR 2008/1333) to add a new food additive, amend the conditions of use for an existing food additive, and makes consequential amendments and corrections.